SHEILA SUELLO: Open Payments
NPI 1285286906 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 11 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $397 · 2025 $501
Food & beverage: $402Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $187 |
| Incyte Corporation | 3 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $98 |
| Merck Sharp & Dohme LLC | 1 | $35 |
| Gamida Cell Inc. | 1 | $24 |
Products named: Cresemba, LIVTENCITY, NIKTIMVO, PREVYMIS, OMISIRGE.
Industry payments across TX — which companies pay providers there.
